InvestorsHub Logo
icon url

sharkey1

11/19/22 3:59 PM

#375804 RE: IB_ #375803

Thank you very much, do you know
The difference between belief and knowing ?
Bullish
Bullish
icon url

The ELTP King

11/19/22 4:04 PM

#375805 RE: IB_ #375803

Nasrat needs to come clean on the following two deals.

If there was already an agreement in place to buy back the Adderalls from Mikah this summer then why the F are we still fooling around with them in other areas.

We have freaking $19 million in cash. Cancel the following two deals IMMEDIATELY.


RELATED PARTY AGREEMENTS WITH MIKAH PHARMA, LLC

- "On December 3, 2018, the Company executed a development agreement with Mikah, pursuant to which Mikah and the Company will collaborate to develop and commercialize generic products including formulation development, analytical method development, bioequivalence studies and manufacture of development batches of generic products. As of March 31, 2021, the Company has incurred costs which are $238,451 in excess of advanced payments received to date from Mikah. This balance due from Mikah was offset, in full, against accrued interest due and owing to Mikah pursuant to the Mikah Note (see Note 7).

- "In June 2021, the Company entered into a development and license agreement with Mikah Pharma LLC, pursuant to which Mikah Pharma LLC will engage in the research, development, sales and licensing of generic pharmaceutical products. In addition, Mikah Pharma LLC will collaborate to develop and commercialize generic products including formulation development, analytical method development, manufacturing, sales and marketing of generic products. Initially two generic products were identified for the parties to develop."


-------------------------------------------------------------------------------------------------------------------------------------